Tonghua Golden-Horse Pharmaceutical Industry (SHE:000766) said Chair and General Manager Zhang Yufu plans to increase his stake by 10 million yuan to 20 million yuan within six months, following the drug registration of ambuciamide succinate tablets on June 25.
Zhang, who currently holds 0.05% of the company, previously completed a similar buyback in March, according to a Wednesday filing with the Shenzhen bourse.
Shares of the drug company closed 2% lower Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments